# Fate Therapeutics Inc: Form 8-K, filed Aug 19, 2020

- Company: [Fate Therapeutics Inc](/companies/fate.md) (CIK 1434316)
- Form: 8-K
- Filed: 2020-08-19
- Accepted by EDGAR: Aug 19, 2020, 16:01 ET
- Period: 2020-08-17
- Accession: 0001564590-20-040672
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1434316/000156459020040672/fate-8k_20200817.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434316/000156459020040672/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434316/000156459020040672/fate-8k_20200817.htm

Filed Aug 19, 2020.
Source: SEC EDGAR, the filing index for accession 0001564590-20-040672. Last ingested by Listed: Nov 14, 2026, 10:50 ET. No prices; not investment advice.
